GSK has reached a near-$1bn deal to acquire 35Pharma, a Canadian biotech that develops drugs for heart and lung diseases, as part of a drive to replenish its pipeline with relatively inexpensive ...

GSK plc GSK announced that it has entered into a definitive agreement to acquire California-based biotech RAPT Therapeutics RAPT for an estimated aggregate equity value of $2.2 billion. The impending ...

LONDON (Reuters) -GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit growth, lifting the British company's shares by nearly 7% to ...

(Bloomberg) -- GSK Plc agreed to buy an experimental medicine for as much as $2 billion to shore up its drug pipeline and muscle into the promising field of liver therapies. The treatment is ready to ...

GlaxoSmithKline ((GSK)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights ...

GSK posted higher profit as sales for its specialty treatments including HIV, cancer and asthma beat expectations, offsetting lower vaccine sales on weak demand in the U.S. GSK plans to bring five new ...

Aug 21 (Reuters) - Dynavax Technologies (DVAX.O), opens new tab said on Thursday its experimental shingles vaccine generated a similar immune response as GSK's (GSK.L), opens new tab blockbuster shot ...

GSK raised its sales and earnings forecasts for the year after its specialty medicines business helped lift sales in the third quarter, the last reporting period with Emma Walmsley at the helm as ...